Connect with us

News

President Biden’s move towards cannabis reform is step closer to justice for consumers

The announcement is a move towards normalising cannabis as both a medicine and a recreational drug, say experts. 

Published

on

Biden's move towards cannabis reform is step closer to justice for consumers

President Biden’s ‘social justice’ and ‘health-based approach’ is a move towards normalising cannabis as both a medicine and a recreational drug, say experts. 

Drug reform experts in the UK and Europe have welcomed a ‘momentous’ decision made by US President Joe Biden on Thursday 7 October, which will ‘undoubtedly’ shift attitudes across the globe. 

President Biden announced in a Twitter thread that he would be pardoning thousands of federal offences for simple cannabis possession and was calling on state governors to do the same.

He is also directing the Department of Justice and the US Attorney General to review how cannabis is classified under federal law.

The move is a significant step forward for cannabis reform which could have far-reaching implications for patients and consumers in the US, but also elsewhere in the world.

Experts in the UK say that not only will this see justice for patients who were thrown in jail as a result of trying to access an effective treatment, but will also open up research opportunities and understanding of cannabis as a medicine. 

“This move will have an important tidal effect on global policy reform for drugs,” Katya Kowalski, head of operations for drug reform group Volteface, told Cannabis Health.

“From Biden’s Tweets yesterday, it’s very clear that he’s taking a social justice and health-based approach to cannabis, realising that locking people up for simply possessing or using it is nonsensical and only serves to do more harm.”

She continued: “His steps towards the reclassification of cannabis also demonstrates a move towards recognising that cannabis is significantly less harmful than opioids and cocaine. This will, if anything, only help to open up medical research and better understanding of the compounds of the drug.

“It is particularly positive from a social justice perspective, in terms of undoing the harms of prohibition. We’re now seeing cannabis normalised as both a recreational drug and a medicine.”

Justice for cannabis consumers

Professor Mike Barnes, chair of the UK Cannabis Industry Council also welcomed the news in the hopes it will influence the UK government to take similar steps.

“So many people have been locked up for so long for simple possession of cannabis, and so many lives have been ruined unnecessarily,” he said.

“From the point of view of the CIC, we must remember that many of those people were just trying to treat their medical conditions and ended up in jail. Let’s hope that this move from the US will at last jolt our own government into action and many more people are enabled to access the medicine they need and deserve. It’s about time.”

In a situation which is echoed in the UK, black people and ethnic minority groups are disproportionately affected by prohibition. According to Release, the UK’s national centre of expertise on drugs and drugs law, black people are 12 times more likely than white people to be prosecuted for cannabis possession, despite being less likely to use the drug.

Niamh Eastwood, executive director of Release, described the decision as ‘momentous’.

“The United States, the original architects of the modern drug war, are now leading the way in dismantling prohibition, at least in respect of cannabis,” she said.

“As Biden acknowledges in his announcement drug law enforcement has disproportionately affected people from racialised communities, a situation that is repeated in the UK.”

The UK remains behind

However, the news comes in the same week that UK Home Secretary Suella Braveman promised to clamp down on cannabis at the Conservative Party conference and follows calls from Conservative police and crime commissioners to make it a Class A substance, which would see harsher penalties for consumers. 

Ms Eastwood continued: “Whilst the US starts to take pragmatic, evidenced-based approaches to cannabis, much of which is grounded in racial and social justice principles, in the UK we are going backwards. The new Home Secretary has just announced her intention to clamp down on cannabis users and three Conservative police and crime commissioners last week called for the drug to be made a Class A substance.”

She added: “It’s quite unbelievable to watch UK political leaders scrambling to look tough on drugs, whilst many parts of the world are moving towards decriminalisation and regulation.”

Whilst Ms Kowalski believes stricter cannabis laws in the UK are unlikely, these comments only encourage ‘fear mongering’ and incite ‘stigma’ and ‘prejudice’ towards consumers. 

“The conversation in the UK needs to move towards harm reduction and to educating people on the harms, but also the medical potential of cannabis,” she said.

“This is a complete backward step when we should be taking an evidence-based approach to cannabis reform.”

Pressure from Europe

Closer to home, countries across Europe are also increasingly moving towards cannabis regulation.

Germany recently announced its plans to legalise cannabis, while Luxembourg and Switzerland are both trialling legal adult-use. 

These developments will be vital in forcing the UK to follow suit, says Ms Kowalski.

She added: “We’re very unlikely to see the desire to reform our cannabis policies from Westminster internally, given the political instability we see now. With that said, I think the only kind of way in which we’ll see reform happen is through pressure and learnings from other countries, along with public appetite.

“We’ve seen a whole flurry of US states go legal over the last two years and a very similar shift across Europe. We are seeing changes and this will undoubtedly shift the UK’s attitude too, it’s only a matter of time.”

Home » News » President Biden’s move towards cannabis reform is step closer to justice for consumers

Sarah Sinclair is a respected cannabis journalist writing on subjects related to science, medicine, research, health and wellness. She is managing editor of Cannabis Health, the UK’s leading title covering medical cannabis and CBD, and sister titles, Cannabis Wealth and Psychedelic Health. Sarah has an NCTJ journalism qualification and an MA in Journalism from the University of Sunderland. Sarah has over six years experience working on newspapers, magazines and digital-first titles, the last two of which have been in the cannabis sector. She has also completed training through the Medical Cannabis Clinicians Society securing a certificate in Medical Cannabis Explained. She is a member of PLEA’s (Patient-Led Engagement for Access) advisory board, has hosted several webinars on cannabis and women's health and has moderated at industry events such as Cannabis Europa. Sarah Sinclair is the editor of Cannabis Health. Got a story? Email sarah@handwmedia.co.uk / Follow us on Twitter: @CannabisHNews / Instagram: @cannabishealthmag

Trending

Cannabis Health is a journalist-led news site. Any views expressed by interviewees or commentators do not reflect our own. All content on this site is intended for educational purposes, please seek professional medical advice if you are concerned about any of the issues raised.

Copyright © 2023 PP Intelligence Ltd.